FINWIRES · TerminalLIVE
FINWIRES

Evercore ISI Upgrades Bio-Techne to Outperform From In Line, Adjusts Price Target to $73 From $50

By

Bio-Techne (TECH) has an average rating of overweight and mean price target of $65.33, according to analysts polled by FactSet.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Related Articles

Research

Barrington Initiates CBIZ at Outperform With $45 Price Target

CBIZ (CBZ) has an average rating of overweight and mean price target of $41.80, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $30.50, Change: $+0.10, Percent Change: +0.33%

$CBZ
Research

Stifel Downgrades Apogee Therapeutics to Hold From Buy, Adjusts Price Target to $135 From $133

Apogee Therapeutics (APGE) has an average rating of overweight and mean price target of $132.64, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $132.93, Change: $+0.05, Percent Change: +0.04%

$APGE
Research

Rothschild & Co Redburn Cuts TUI Group's PT, Affirms Buy Rating

Rothschild & Co Redburn on Wednesday lowered the price target for German travel services company TUI Group (TUI1.F) to 11.00 euros from 13.60 euros and kept its rating at buy.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$TUI1.F